KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW 4,605.00
+30.00 (0.66%)
Last updated: Mar 25, 2025
KoBioLabs Revenue
In the year 2024, KoBioLabs had annual revenue of 68.36B KRW with 106.28% growth. KoBioLabs had revenue of 17.65B in the quarter ending December 31, 2024, with 66.77% growth.
Revenue
68.36B
Revenue Growth
+106.28%
P/S Ratio
1.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
83.31B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |